Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined immunosuppression and radiotherapy in thyroid eye disease
2004-002547-27Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azathioprine and prednisolone in Graves Orbitopathy (GO) (4 arms), sponsored by University of Bristol. Primary endpoints: Clinical Activity Score and Composite Binary Clinical Outcome Measure. Started Aug 2005; status: completed.
02
Drugs
azathioprineprednisolone
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on 2004-002547-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002547-27.